tiprankstipranks
Pelthos Therapeutics (PTHS)
:PTHS
US Market
Want to see PTHS full AI Analyst Report?

Pelthos Therapeutics (PTHS) Ownership - Who Owns Pelthos Therapeutics?

77 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 15, 2026
xxxxxxxxxxxxx
$999817
May 26, 2026
xxxxxxxxxxxxx
$40260
Nov 26, 2025
xxxxxxxxxxxxx
$280261

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2026
xxxxxxxxxxxxx
$632007

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,575,834Insider41.16%34,510,765
1,500,000Insider39.18%32,850,000
203,114Insider5.31%4,448,197
94,136Institution2.46%2,061,578
91,004Institution2.38%1,992,988
40,841Insider1.07%894,418
28,462Insider0.74%623,318
23,884Insider0.62%523,060
22,364Institution0.58%489,772
14,364Insider0.38%314,572

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
91,004Institution2.38%1,992,988
10,835Institution0.28%237,286
2,089Institution0.05%45,749

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
78,008Institution2.04%2,235,709
16,128Institution0.42%462,228
4,958Institution0.13%108,580

FAQ

Who Owns Pelthos Therapeutics (PTHS)?
Currently, no data Available
What percentage of Pelthos Therapeutics (PTHS) stock is held by institutional investors?
Currently, no data Available
What percentage of Pelthos Therapeutics (PTHS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Pelthos Therapeutics (PTHS)?
Todd Davis owns the most shares of Pelthos Therapeutics (PTHS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.